Abstract
Neuroimaging is a key tool in the diagnosis and follow-up of neuro-oncologic patients. Magnetic resonance imaging (MRI) and computerized tomography (CT) are the main imaging modalities involved in neuroimaging diagnosis. These two imaging modalities are different regarding imaging acquisition principles and techniques. One of the main differences between them is that CT uses ionizing radiation for imaging acquisition while MRI uses a magnetic field. MRI imaging also has the advantage over CT as it demonstrates significantly more details of the tissues and the anatomy of the brain. Therefore, because of the risks related to radiation exposure and lack of additional information as compared to MRI, CT is a less attractive method to image the head.
PET (positron emission tomography) and molecular imaging are rapidly developing as new techniques to evaluate brain tumor. The results provided by PET and molecular imaging appear to corroborate the findings of MRI studies and may contribute to decision-making in the treatment and follow-up of patients. Therefore, understanding general principles of imaging acquisition and interpretation can help the clinician to improve patient care.
The aim of this chapter is to describe standard MRI and CT imaging acquisition techniques, basic principles of imaging interpretation, as well as radiation safety principles. New imaging techniques will also be visited together with the influence that these may have on day-to-day practice in the future.
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Neuroimaging
- Magnetic resonance (MRI)
- Radiation safety
- Computerized tomography (CT)
- Advanced imaging techniques
Introduction
Neuroimaging is a key tool in the diagnosis and follow-up of neuro-oncologic patients. Magnetic resonance imaging (MRI) and computerized tomography (CT) are the main imaging modalities involved in neuroimaging diagnosis of these patients. However, MRI is the main imaging tool in the daily practice of pediatric neuro-oncology. The main reason is that CT involves radiation exposure risks and MRI has the ability to show significant more details about the brain parenchyma.
PET (positron emission tomography) and molecular imaging are rapidly developing as new techniques to evaluate brain tumor. The results provided by PET and molecular imaging appear to corroborate the findings of MRI studies and may contribute to decision-making in the treatment and follow-up of patients. Therefore understanding general principles of different imaging modalities can help the clinician to improve patient care.
CT Principles
Neuroimaging is essential for diagnosis of both primary and secondary central nervous system (CNS) neoplasms, and magnetic resonance imaging (MRI) remains the main imaging modality for characterization of these lesions. However, computerized tomography (CT) is often used in patients with acute presentations. The two main reasons that CT may be preferred over MRI in cases presenting acutely are: faster image acquisition than MRI, within few seconds, and diagnostic images are accrued more rapidly, which is important if the patient’s clinical status is unstable. In addition, there is rarely a need for sedation [1] and CT may often be more instantly available than MRI [2]. However, a downside of CT is the ionizing radiation exposure, of particular importance in children who are more sensitive to its effects than adults (Fig. 4.1) [3].
Radiation Safety
Biological radiation effects can be divided into two categories: stochastic and deterministic effects. Deterministic effects are set by exposure threshold, and doses above the cutoff cause damage (e.g., cataract occurs if the crystalline lenses are exposed above 5 Gy (gray is the radiation unit for absorbed dose of radiation)) [3]. Stochastic effects are the result of cumulative doses of radiation and are related to genetic abnormalities and carcinogenic effects. There are no safe levels of radiation exposure related to stochastic effects, and the cancer risk increases as cumulative doses increase [3].
Recently, Pearce et al. (2012) demonstrated the association of low doses of radiation administrated on CT with occurrence of brain tumors and leukemia in a pediatric population (Fig. 4.2). This was the first time that this association was proven, although previous publications based on information gathered from the survivors following atomic explosions had raised the concern about the use of low dose radiation in medical imaging modalities [4]. Therefore, extra care should be taken when requesting a CT scan in the pediatric population, weighing the risks and benefits for each case.
There are three principles of radiation safety that should be kept in mind when requesting and performing a CT examination: justification, optimization, and dose limitation (Table 4.1) [5].
The North American radiological societies have mounted campaigns in an effort to educate doctors and the general population regarding radiation effects and radiation safety. The most important radiation safety campaigns (Image Gently® for pediatric population (http://www.pedrad.org/associations/5364/ig/) and Image Wisely® for the adult population (http://www.imagewisely.org/)) have made optimization (“as low as reasonably achievable” (ALARA)) a very popular principle. However, justification is also very important, not only because it justifies the investigation, but also because it helps to decide which adjustments are necessary in the imaging technique in order to make the diagnosis.
There are several techniques that can be applied in CT imaging acquisition. For example, a patient who needs to have only the size of the cerebral ventricles assessed can have a study performed with low radiation exposure. In contrast, for brain parenchyma assessment, a scan with a regular radiation dose exposure is required to prevent artifacts related to low doses [6] (Fig. 4.3).
The clinical information provided in the request form also helps the radiologist to decide if the study requires contrast. For example, melanoma metastases are easier to depict after intravenous contrast injection. However, if the radiologist is not informed about a clinical suspicion of melanoma, intravenous contrast might not be used, thereby increasing the chance of missing lesions. The same problem applies for leptomeningeal disease in patients with history of malignancy as this can be difficult to visualize without the administration of intravenous contrast media as illustrated in Figs. 4.4 and 4.5.
The contrast used in CT scans is an iodine-based media. The use of this contrast should be cautious since it is not innocuous and contraindications to its use must be taken into account (Table 4.2) [7]. In addition, if a pre- and post-contrast study is needed, the patient will need to be scanned twice, receiving two doses of radiation.
In conclusion, every time a physician fills out a requisition with adequate clinical information, the radiologist is being helped to decide if the image modality chosen by the clinician is the most appropriate for the diagnosis and what is the best technical approach to perform it. The clinician must also flag any risk factors or contraindications for the use of contrast media. The chosen diagnostic test will have adequate sensitivity and specificity and patients will be saved from unnecessary radiation exposure if all these principles are followed.
Here are some questions that might help physicians to evaluate the appropriateness of a CT request:
-
Are there publications or protocols to support the choice of a CT study for the condition?
The American College of Radiology website (http://www.acr.org/Quality-Safety/Appropriateness-Criteria) has published a list of appropriateness criteria for different clinical scenarios. The use of this website may be helpful when questions about appropriateness are raised.
-
In the knowledge that the younger the patient, the greatest the risk for tumors related to radiation exposure, does the benefit of a CT diagnosis outweigh the risk of cancer?
-
Is there any contraindication to iodine contrast media if this is needed for the imaging study?
-
What is the history of previous radiation exposure? Is this patient pregnant or at risk of pregnancy?
-
Are there alternative tests available for the diagnosis?
Basic Principles of CT Interpretation
CT image formation is based on a gray scale of tissue X-ray attenuation. Tissues that can attenuate more X-rays appear whiter or hyperdense (e.g., bone) and tissues that allow the passage of X-rays appear blacker or hypodense (e.g., cerebrospinal fluid spaces). Fat tissue, for example, attenuates less X-rays than the normal brain tissue and therefore appears hypodense (Fig. 4.6) [8].
CT is a very good technique to assess the CNS vasculature. CT arteriograms and venograms have a high sensitivity and specificity in the diagnosis of vascular disease. Nevertheless, because of the increased radiation exposure, it is normally only used if the MR arteriogram/venogram was not diagnostic.
Interpretation of pediatric imaging has its own peculiarities as compared to adult imaging, as the different stages of development result in different appearances of the normal brain. The lack of myelin in the early stages of development and increased water content in the white matter is one example. This characteristic results in differences between the gray and white matter contrast that does not resemble what is seen in an older child, when the myelination process is complete (Fig. 4.7). Therefore, when looking at a pediatric study, it is very important to know the patient’s age before coming to any conclusions. The same principles apply for the interpretation of MRI images [9].
The assessment of a CNS bleed also has some pitfalls. There are different stages of hemoglobin degradation (Table 4.3) [10, 11]. In acute stages a bleed will be hyperdense compared with the rest of the brain parenchyma. However, if the patient is anemic, the attenuation of the signal from an acute bleed can be similar to that of the brain parenchyma. Therefore, a small bleed can be easily missed. Another problem is the lack of myelin in young children, which produces a relative diffuse hypodensity of the parenchyma and makes the blood vessels (in particular the venous sinuses) appear more hyperdense than usual (Fig. 4.8). This should not be confused with acute thrombosis of the venous sinuses. A similar effect can be seen in patients with cyanotic conditions such as cardiac shunts or chronic lung disease, if they are polycythemic. However, in these cases the relative hyperdensity of the vessels is caused by an increased hematocrit and is not due to lack of myelin [11].
A CT scan can determine the degree of mass effect over the parenchyma when evaluating a space-occupying lesion. It can also demonstrate the presence of intralesional cysts, calcification, necrosis, blood, or fat. CT almost always defines the anatomical location of the lesion, except in some cases of infiltrative lesions and posterior fossa lesions. However, MRI allows a more detailed assessment of brain anatomy and its associated pathology (Fig. 4.9). Therefore, once a space-occupying lesion is identified on CT, an MRI is carried out as the next step in the imaging investigation to further characterize the mass and its relationship to the rest of the parenchyma.
Magnetic Resonance Imaging
MRI Image Formation
The principle of MRI imaging acquisition is based on the spin movement of hydrogen atoms. Intermittent radiofrequency pulses are turned on to cause resonance of these atoms. The atomic resonance is extinguished when the radiofrequency pulse is turned off. At this moment, there is a relaxation period while the atoms are losing resonance in which a radiofrequency pulse is emitted by the atoms and then captured by the MRI coils (a device placed around the patient which acts as a receptor), giving the necessary information for the image formation. The set of images obtained with a specific combination of radiofrequencies is called a sequence.
Depending on how the radiofrequency pulse is applied, the sequences can highlight the signal of water (T2-weighted images) or the signal of fat tissue (T1-weighted images). Other radiofrequency combinations result in different sequences and other contrasts (e.g., proton density-weighted imaging). The study protocol details are the combination of sequences. There are several types of MRI sequences (e.g., spin echo (SE), turbo spin echo (TSE), FLAIR (fluid-attenuated inversion recovery), and susceptibility-weighted image (SWI)).
The clinical history provided by the physician will help the radiologist to set up the MRI protocol and to make the decision regarding the need for intravenous contrast administration. Standard MRI protocols of the brain and spine vary among institutions. In our institution, the standard brain tumor imaging protocols are volumetric sagittal T1 with reconstructions, coronal T2 TSE, axial FLAIR, axial diffusion-weighted image (DWI), and axial SWI (Table 4.4). A volumetric gradient T1 with reconstructions is applied after intravenous gadolinium contrast media administration.
Accurate anatomical localization of a space-occupying lesion is the key for the differential diagnosis of a brain tumor in the pediatric population. Nevertheless, signal intensity, presence of restricted diffusion, calcifications, fat, hemorrhage, and enhancement pattern of the lesion are additional features that help to narrow down the differential diagnosis [12].
The routine MRI sequences are usually enough for an accurate differential diagnosis (Fig. 4.10). Nevertheless, newer sequences and techniques provide additional information to help in the diagnosis and treatment management of difficult and atypical cases.
Commonly, neuro-oncology MRI studies will need post-contrast imaging for the characterization of a space-occupying lesion. Particular attention should be paid to studies post-surgery. Ideally, these should be performed within the first 24 h after a surgical procedure in order to avoid misinterpretations of residual tumor enhancement with leakage across the blood–brain barrier. Enhancement of the surgical bed due to such leakage starts within 72 h after surgery and is maintained clearly for up to 6–8 weeks, decreasing progressively for up to 12 months after surgery. A further aspect post-intervention is the enhancement of lesions 4–6 months after radiotherapy, which may be related to radiation necrosis [13]. In these cases frequent follow-up is necessary, and other MRI techniques can be used in an attempt to differentiate radiation necrosis from tumor recurrence.
MRI Special Considerations
MRI contrast media are gadolinium-based agents, and its use in the pediatric population is off-label for individuals younger than 2 years. Gadolinium-based contrast media is not nephrotoxic in the approved dosages for MRI studies [7]. However, patients with previous renal failure can develop nephrogenic systemic fibrosis (NSF) if gadolinium-based contrast is administered. NSF is a rare irreversible disease. The hypothesis is that it is caused by deposition of gadolinium in the tissues. To date, there are approximately 370 cases reported in the literature associating this pathology to the use of gadolinium contrast. The age range of reported cases is from 8 to 87 years [14]. The majority of NSF cases are described in patients with previous chronic renal failure. Patients with acute renal failure can also develop NSF especially if superimposed to chronic renal failure. Due to the risk of NSF, the procedure of administering gadolinium-based contrast “just in case” has been removed from the daily practice. The American College of Radiology also advocates cautious use of gadolinium-based agents in newborn and infants due to renal immaturity, even though no case has been reported in patients younger than 8 years [7].
Enhanced CT is the alternative for patients at increased risk of NSF that need an enhanced study, but iodine contrast media can potentially worsen the renal function. In addition, the risk of ionizing radiation needs to be weighed up in the risk-benefit analysis when a CT study with contrast is carried out instead of an MRI especially in the pediatric population. However, CT iodine contrast can be removed from the blood stream through hemodialysis. It is unknown if hemodialysis performed soon after an enhanced MRI scan to remove gadolinium from the blood stream can prevent NSF. Nevertheless, this practice is advised if the enhanced MRI study is indeed performed [7].
Imaging Artifacts
MRI is a technique that is highly susceptible to imaging artifacts. In brain imaging, artifacts related to dental hardware are very common and it may be impossible to diagnose any pathology. Motion artifact is another common artifact in pediatric studies, and this can also degrade the quality of images significantly (Fig. 4.11). For this reason some pediatric MRI studies need to be performed under sedation.
MRI Safety
Another important consideration is the MRI safety area and procedures. When approaching the area of an MRI scanner, safety zone alerts should be evident. Metallic objects can fly towards the magnet due to the magnetic field strength and this can be deadly. Patients with metallic implants can have the implant damaged or displaced. Injury can also occur by heat of a metallic foreign body or implant. Anyone that approaches an MRI scanner should be initially screened for the presence of metallic hardware and other contraindications (Table 4.5) [15].
Pediatric Sedation
Imaging pediatric patients can be challenging. Motion artifact can ruin an MRI or CT study. Therefore, sedation may be needed to perform an imaging examination.
The age group most likely to require sedation is for children younger than 8 years.
Overall, the failure rate of sedation varies in the literature from 1 to 20 % [16]. In addition, major cardiovascular and respiratory events can occur in approximately 0.4–1 % [17]. Alternative techniques are safer for the patients and can avoid a significant number of sedations. Audiovisual systems in the MRI suits, for example, can reduce the number of sedations in children between 3 and 10 years old by 25 % and by 50 % in children older than 10 years [18]. Other examples of alternative techniques are feed and sleep (which works very well in neonates and young infants), sleep deprivation, melatonin administration, and MRI simulation training. Alternative techniques should be applied whenever is possible [19].
Advanced Imaging Techniques
Functional MRI (fMRI)
Imaging acquisition in fMRI is based in the principle that oxygen consumption increases in the brain area used for a particular activity. The sequence used for this technique is known as blood-oxygen-level-dependent (BOLD) contrast. In neuro-oncology this technique can add information about involvement of eloquent areas of the brain by a space-occupying lesion (Fig. 4.12) [20].
Functional studies are carried out with the patient awake and able to collaborate [20]. Standard MRI scanners might have the BOLD sequence available; however, special software is necessary to perform the functional examinations.
Diffusion Tensor Imaging (DTI)
DTI imaging principle is based in the three directional movements of water molecules throughout the tissues. Isotropy is the term used when the water molecules diffuse equally in all directions. However, in the brain, due to the parallel micro movement of water molecules within the axons, there is anisotropy of water molecule movement, which is measured by the fractional anisotropy (FA) index. DTI also allows determination of fiber bundle directionality, also known as tractography study [21].
Nowadays, tractography studies have been used alone or in association with fMRI to determine the degree of white matter tract involvement by a CNS tumor (Fig. 4.13). This information is extremely helpful for surgical and radiotherapy treatment planning, especially if the tumor is located in an eloquent region of the brain [21].
A promising application of DTI technique in neuro-oncology is the FA index measurement in high-grade gliomas. This measurement may help to detect infiltrative portions of the tumor and differentiate it from perilesional edema [22]. It also could potentially help to depict tumor recurrence. However, further research in this area is being performed to prove this use of DTI. Patients with medulloblastoma who have received radiation and present with decreased cognitive function have shown low FA index measurements in the brainstem, even though the overall imaging of the brainstem may be normal [23].
Unfortunately, FA index measurements and tractography studies are not carried out in the daily practice of most institutions since such techniques demand special software reconstructions that are not always available.
3D Imaging and Stereotaxy
3D imaging (or volumetric imaging) is extremely helpful for anatomical reconstructions. There are several different MRI sequences that can be acquired as volumetric images. Several different kinds of reconstructions also can be performed from it if adequate software is available.
In neuro-oncology, 3D imaging is especially used for stereotaxy. Stereotaxy is a technique that makes use of 3D imaging to create a coordinate system that will guide the localization of a lesion in a surgical procedure or radiotherapy treatment. Nowadays it is associated with other techniques, such as fMRI and direct cortical stimulation, to reduce morbidity in CNS tumor resection especially if the lesion is located in eloquent areas of the brain [24]. Association of 3D MRI imaging with other imaging modalities such as positron emission tomography (PET) scan is possible and it has been studied to improve surgical and radiotherapy planning.
Spectroscopy
MR spectroscopy (MRS) is a technique widely used in brain imaging. It is used to assess metabolites in the brain parenchyma and lesions. The results of an MRS acquisition are typically displayed in a graphic of metabolite peaks. Each metabolite has its own location in the MRS graphic and the height of the peak indicates its concentration in the parenchyma (Fig. 4.14). The most commonly assessed metabolites are choline, creatine, N-acetylaspartate (NAA), and lactate.
Choline is a substance related to the cell membrane and it is elevated therefore in situations in which there is increased cell density and high cellular turnover. Creatine is related to the cell’s metabolic rate. NAA is a protein present in the cells, which reflects the neuronal density. The most common spectral signature of a brain tumor is increased choline and decreased NAA compared to creatine peaks. If present, lactate peak usually reflects areas of ischemia and necrosis within the tumor, suggesting a higher grade tumor. The lipids peak is related to cell proliferation. Therefore this peak is usually present in high-grade CNS tumors [13].
Attempts have been made in the use of MRS to determine the type and grading of CNS tumors. However, there is a significant overlap of metabolite peaks pattern that exists between low- and high-grade CNS tumors as well as between neoplastic and nonneoplastic lesions. For example, pilocytic astrocytoma and oligodendrogliomas are low-grade tumors that may have a similar MRS spectrum to that of a high-grade tumor [13].
In general, MRS does not add much information to the differential diagnosis of an initial investigation. Nevertheless, it has been shown to be useful in some atypical cases differentiating brain tumor from brain abscess. It can also potentially help to differentiate areas of radiation necrosis or postsurgical changes from recurrent or residual tumor. Ratios between choline peak and other peaks such as creatine and NAA peaks can also be helpful in assessing response of therapy.
Perfusion Techniques
Perfusion technique can be applied with both MRI and CT. However, CT perfusion is usually not performed in the pediatric population due to the risks involved in radiation exposure.
The standard perfusion technique uses intravenous contrast. Nevertheless, there is a new MRI sequence called arterial spin labeling (ASL) that can be used to study brain perfusion without the use of contrast media. This technique does not require IV access and avoids the off-label use of gadolinium contrast media in patients younger than 2 years [13].
The perfusion images are frequently interpreted in a color map. The red zones usually demonstrate increased perfusion and the blue zones decreased perfusion. More detailed analysis can also be made with numerical estimations of cerebral blood volume using post-processing techniques.
Research studies suggest that perfusion technique may help to differentiate between low- and high-grade tumors. It also has been described to help in the differentiation of radiation necrosis (decreased perfusion) from tumor recurrence (normal to elevated perfusion) (Fig. 4.15) [25]. Another application of this technique is to help in defining an ideal area for surgical biopsy, avoiding areas of necrosis. It can be used in association with MRS for this purpose. Future applications of this technique are related to evaluation of tumor angiogenesis and treatment response in patients using antiangiogenic drugs [13].
Unfortunately, MRI perfusion technique is not available in all institutions since it is not a standard MRI sequence.
PET Scan and Future Molecular Imaging
PET scan is considered to be a conventional molecular technique. Its principle is based on the injection of a radiopharmaceutical containing a positron-emitting radionuclide (tracer) into the body. This tracer emits two gamma rays in opposite directions to the imaging receptor located in the PET scanner forming the image. The highlighted areas in the images usually demonstrate higher concentration of the radiopharmaceutical in the tissues. The main difference between PET and single-photon emission computed tomography (SPECT) is that the gamma-emitting radionuclide used in SPECT produces a random emission of gamma rays, while in PET the emission of gamma rays is always in opposite directions (180°) giving better resolution. Use of a PET scan is often carried out together with low dose CT images or MRI to improve the anatomical analysis. The difference between PET/SPECT scan from CT scan is that the radiation source is within the patient while in CT the source is external.
Radiopharmaceuticals are radionuclides bonded to specific biological markers. Numerous radiopharmaceuticals are available and each one has a special diagnostic or treatment target. Common radiopharmaceuticals applied in brain imaging are fludeoxyglucose (FDG), L-[methyl-11C]methionine ([11C]MET), and 3′-deoxy-3′-[18 F]fluorothymidine ([18F]FLT).
Neoplastic lesions demonstrate increase uptake of FDG in PET studies due to increased glucose metabolism (Fig. 4.16). Thus an FDG scan can be used in the evaluation of tumor grading, localization for biopsy, differentiation of radiation necrosis from tumor recurrence, therapeutic monitoring, and assessment for malignant transformation of what were originally low-grade gliomas [26]. However, its applicability in clinical practice is low because normal gray matter also demonstrates increased glucose metabolism, effacing lesions.
L-[methyl-11C]methionine ([11C]MET) is an amino acid-based agent. The advantage of this radiopharmaceutical over FDG is that it does not have a high uptake by the normal brain parenchyma. It has been used to differentiate neoplastic from nonneoplastic lesions and to differentiate recurrence from radionecrosis [26].
3′-deoxy-3′-[18F]fluorothymidine ([18F]FLT) is a marker for cell proliferation since it is trapped by thymidine kinase, an intracellular proliferation pathway enzyme. It is useful to differentiate recurrence from radionecrosis and in differentiation of low- and high-grade tumors [26].
MR-based molecular imaging is another example of molecular imaging technique. MR molecular imaging can be based on physical principles of imaging acquisition or on the use of special combinations of gadolinium with specific macromolecules or nanoparticles.
MRS is an example of MR-based molecular imaging since it demonstrates presence and quantities of different metabolites. Its applicability in neuro-oncology was described previously in this chapter. Nowadays, a significant amount of research has been carried out using a new MRI technique called chemical exchange saturation transfer (CEST) imaging. This technique is able to image specific molecules. Amide proton transfer (APT) imaging is a type of CEST imaging that has been used in studies of brain tumor. This technique is able to depict endogenous mobile proteins and peptides in the tissues. Potentially it may be able to assess tumor boundary and detect tumor recurrence [27].
A large number of special combinations of gadolinium and nanoparticles have been investigated in preclinical research projects. The hypothesis is to explore the possibility of this type of gadolinium contrast acting in a similar way as a radiopharmaceutical. This is another promising research field in MRI techniques, which could revolutionize brain tumor imaging in the near future.
References
Kaste SC, Young CW, Holmes TP, Baker DK. Effect of helical CT on the frequency of sedation in pediatric patients. AJR Am J Roentgenol. 1997;168(4):1001–3. PubMed PMID: 9124104.
Ginde AA, Foianini A, Renner DM, Valley M, Camargo Jr CA. Availability and quality of computed tomography and magnetic resonance imaging equipment in U.S. emergency departments. Acad Emerg Med. 2008;15(8):780–3.
Peck DJ, Samei E. How to understand and communicate radiation risk. Image Wisely; American College of Radiology; 2010. http://www.imagewisely.org/Imaging-Professionals/Medical-Physicists/Articles/How-to-Understand-and-Communicate-Radiation-Risk?referrer=search. Accessed 24 Apr 2013.
Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet. 2012;380(9840):499–505. PubMed PMID: 22681860. Pubmed Central PMCID: 3418594.
IAEA. Radiation, people and the environment: a broad overview of ionizing radiation, its effects and uses, as well as the measures in place to use it safely. Vienna: IAEA; 2004. p. 23–8.
Udayasankar UK, Braithwaite K, Arvaniti M, Tudorascu D, Small WC, Little S, et al. Low-dose nonenhanced head CT protocol for follow-up evaluation of children with ventriculoperitoneal shunt: reduction of radiation and effect on image quality. AJNR Am J Neuroradiol. 2008;29(4):802–6. PubMed PMID: 18397968.
ACR Manual on Contrast Media - version 8. ACR Committee on Drugs and Contrast Media. American College of Radiology; 2012.
Senggen E, Laswed T, Meuwly JY, Maestre LA, Jaques B, Meuli R, et al. First and second branchial arch syndromes: multimodality approach. Pediatr Radiol. 2011;41(5):549–61. PubMed PMID: 20924574.
Barkovich AJRC. Pediatric neuroimaging. Philadelphia: Lippincott Williams & Wilkins; 2012. p. 20–80.
Parizel PM, Makkat S, Van Miert E, Van Goethem JW, van den Hauwe L, De Schepper AM. Intracranial hemorrhage: principles of CT and MRI interpretation. Eur Radiol. 2001;11(9):1770–83. PubMed PMID: 11511901.
Osborn AG. Osborn’s brain: imaging, pathology and anatomy. 1st ed. Philadelphia: Amirsys and Lippincott Williams & Wilkins; 2012. p. 215–43.
Barkovich AJ, Raybaud C. Pediatric neuroimaging. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2012. p. 637–807.
Rao P. Role of MRI in paediatric neurooncology. Eur J Radiol. 2008;68(2):259–70. PubMed PMID: 18775616.
Zou Z, Zhang HL, Roditi GH, Leiner T, Kucharczyk W, Prince MR. Nephrogenic systemic fibrosis: review of 370 biopsy-confirmed cases. JACC Cardiovasc Imaging. 2011;4(11):1206–16. PubMed PMID: 22093272.
Expert Panel on MRS, Kanal E, Barkovich AJ, Bell C, Borgstede JP, Bradley Jr WG, et al. ACR guidance document on MR safe practices: 2013. J Magn Reson Imaging. 2013;37(3):501–30. PubMed PMID: 23345200.
Cravero JP, Blike GT. Review of pediatric sedation. Anesth Analg. 2004;99(5):1355–64. PubMed PMID: 15502031.
Sanborn PA, Michna E, Zurakowski D, Burrows PE, Fontaine PJ, Connor L, et al. Adverse cardiovascular and respiratory events during sedation of pediatric patients for imaging examinations. Radiology. 2005;237(1):288–94. PubMed PMID: 16183936.
Harned 2nd RK, Strain JD. MRI-compatible audio/visual system: impact on pediatric sedation. Pediatr Radiol. 2001;31(4):247–50. PubMed PMID: 11321741.
Edwards AD, Arthurs OJ. Paediatric MRI under sedation: is it necessary? What is the evidence for the alternatives? Pediatr Radiol. 2011;41(11):1353–64. PubMed PMID: 21678113.
Stippich C. Preoperative Blood Oxygen Level Dependent (BOLD) functional Magnetic Resonance Imaging (fMRI) of motor and somatosensory function. In: Ulmer S, Jansen O, editors. FMRI: basics and clinical applications. Heidelberg: Springer; 2013. p. 91–110.
Assaf Y, Pasternak O. Diffusion tensor imaging (DTI)-based white matter mapping in brain research: a review. J Mol Neurosci. 2008;34(1):51–61. PubMed PMID: 18157658.
De Belder FE, Oot AR, Van Hecke W, Venstermans C, Menovsky T, Van Marck V, et al. Diffusion tensor imaging provides an insight into the microstructure of meningiomas, high-grade gliomas, and peritumoral edema. J Comput Assist Tomogr. 2012;36(5):577–82. PubMed PMID: 22992609.
Palmer SL, Glass JO, Li Y, Ogg R, Qaddoumi I, Armstrong GT, et al. White matter integrity is associated with cognitive processing in patients treated for a posterior fossa brain tumor. Neuro Oncol. 2012;14(9):1185–93. PubMed PMID: 22898373. Pubmed Central PMCID: 3424215.
Stapleton SR, Kiriakopoulos E, Mikulis D, Drake JM, Hoffman HJ, Humphreys R, et al. Combined utility of functional MRI, cortical mapping, and frameless stereotaxy in the resection of lesions in eloquent areas of brain in children. Pediatr Neurosurg. 1997;26(2):68–82. PubMed PMID: 9419036.
Chernov MF, Ono Y, Abe K, Usukura M, Hayashi M, Izawa M, Diment SV, Ivanov PI. Differentiation of tumor progression and induced effects after intracranial radiosurgery. Acta Neurochir Suppl. 2013;116:193–210.
Petrirena GJ, Goldman S, Delattre JY. Advances in PET imaging of brain tumors: a referring physician’s perspective. Curr Opin Oncol. 2011;23(6):617–23. PubMed PMID: 21825989.
Zhou J, Tryggestad E, Wen Z, Lal B, Zhou T, Grossman R, et al. Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med. 2011;17(1):130–4. PubMed PMID: 21170048. Pubmed Central PMCID: 3058561.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Stein, N.R., Ribeiro, L.T. (2015). Pediatric Neuroimaging. In: Scheinemann, K., Bouffet, E. (eds) Pediatric Neuro-oncology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1541-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1541-5_4
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1540-8
Online ISBN: 978-1-4939-1541-5
eBook Packages: MedicineMedicine (R0)